Removing Race Correction From Lung Function Test Changes Clinical Management
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
WEDNESDAY, Aug. 30, 2023 -- Removal of race correction from pulmonary function tests (PFTs) may change surgical management of lung cancer in African American patients, according to a study published Aug. 16 in JAMA Surgery.
Sidra N. Bonner, M.D., M.P.H., from the University of Michigan in Ann Arbor, and colleagues aimed to identify how many hospitals providing lung cancer surgery use race correction, examined the association of race correction with predicted lung function, and tested the effect of hypothetical vignettes on surgeons’ treatment recommendations for African American patients. The analysis included data from 515 African American patients who underwent lung cancer resection between Jan. 1, 2015, and Sept. 31, 2022.
The researchers found that 15 of 16 hospitals performing lung cancer resection for African American patients in Michigan reported using race correction, corresponding to 91.8 percent of African American patients having race-corrected PFTs. If race-neutral equations had been used, the percent predicted preoperative forced expiratory volume in 1 second (FEV1) and postoperative FEV1 would have decreased by 9.2 percent (P < 0.001) and 7.6 percent (P < 0.001), respectively. Among 225 cardiothoracic surgeons who completed treatment recommendations based on a randomized vignette, surgeons randomly assigned to the vignette with African American race-corrected PFTs were more likely to recommend lobectomy (79.2 percent) versus surgeons randomly assigned to the other race or multiracial-corrected vignette (61.7 percent; P = 0.02) or race-neutral PFTs (52.8 percent; P = 0.001).
“It is important that race-correction in spirometry tests is removed given that it is based on the flawed concept of race as a biological factor,” Bonner said in a statement. “For African Americans with lung cancer being evaluated for surgery, this may exacerbate existing disparities in lung cancer care.”
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Positive Family Relationships May Protect Against Pain in Older Adults
FRIDAY, June 14, 2024 -- Family support may protect against pain incidence and persistence among aging African Americans, according to a study published online May 20 in...
First Responders With More Debris Exposure Have Higher Risk of Early Dementia
FRIDAY, June 14, 2024 -- More severe exposure to dust or debris among World Trade Center (WTC) responders is significantly associated with a higher risk of dementia at <65...
1990 to 2019 Saw Increase in Life Expectancy in Seniors With T1DM
FRIDAY, June 14, 2024 -- From 1990 to 2019, there was an increase in life expectancy in older people with type 1 diabetes mellitus (T1DM), according to a study published online...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.